Colestipol Hydrochloride



Indications and Reactions:

Role Indications Reactions
Primary
Blood Cholesterol Increased 23.5%
Diarrhoea 14.7%
Hyperlipidaemia 11.8%
Abdominal Discomfort 8.8%
Seasonal Allergy 8.8%
Bile Acid Malabsorption 5.9%
Blood Cholesterol 5.9%
Back Pain 2.9%
Biliary Tract Disorder 2.9%
Blood Cholesterol Abnormal 2.9%
Blood Triglycerides 2.9%
Fibromyalgia 2.9%
Heart Injury 2.9%
Hypercholesterolaemia 2.9%
Drug Ineffective 18.5%
Dysphagia 7.4%
Myalgia 7.4%
Vomiting 7.4%
Abdominal Discomfort 3.7%
Blood Cholesterol Increased 3.7%
Blood Triglycerides Increased 3.7%
Chest Discomfort 3.7%
Chills 3.7%
Choking 3.7%
Dizziness 3.7%
Face Oedema 3.7%
Foreign Body 3.7%
Gynaecomastia 3.7%
Hot Flush 3.7%
Hypersensitivity 3.7%
Malaise 3.7%
Nausea 3.7%
Off Label Use 3.7%
Pain 3.7%
Secondary
Diarrhoea 25.6%
Blood Cholesterol Increased 19.5%
Gastrooesophageal Reflux Disease 17.1%
Hypertension 14.6%
Abdominal Discomfort 3.7%
Crohn's Disease 3.7%
Seasonal Allergy 3.7%
Blood Cholesterol 2.4%
Cardiac Disorder 2.4%
Anaemia 1.2%
Anticoagulant Therapy 1.2%
Heart Injury 1.2%
Pain 1.2%
Thyroid Disorder 1.2%
Vitamin Supplementation 1.2%
Muscle Tightness 14.3%
Myalgia 14.3%
Muscle Spasms 10.7%
Abdominal Distension 7.1%
Abdominal Pain Upper 7.1%
Blood Cholesterol Increased 3.6%
Choking 3.6%
Drug Hypersensitivity 3.6%
Drug Ineffective 3.6%
Feeling Cold 3.6%
Movement Disorder 3.6%
Nausea 3.6%
Pericardial Effusion 3.6%
Restless Legs Syndrome 3.6%
Retching 3.6%
Visual Impairment 3.6%
Walking Aid User 3.6%
Weight Increased 3.6%
Concomitant
Product Used For Unknown Indication 29.0%
Crohn's Disease 14.9%
Drug Use For Unknown Indication 14.7%
Cardiac Disorder 4.2%
Hypertension 3.6%
Pain 3.1%
Anxiety 2.9%
Blood Cholesterol Increased 2.9%
Diarrhoea 2.8%
Vitamin Supplementation 2.7%
Depression 2.6%
Nausea 2.5%
Gastrooesophageal Reflux Disease 2.2%
Contraception 2.1%
Type 2 Diabetes Mellitus 2.0%
Supplementation Therapy 1.7%
Rheumatoid Arthritis 1.6%
Blood Cholesterol 1.5%
Fibromyalgia 1.5%
Vomiting 1.4%
Tremor 10.5%
Flushing 8.9%
Vomiting 8.9%
Diarrhoea 8.1%
Pain 7.3%
Visual Acuity Reduced 7.3%
Progressive Multifocal Leukoencephalopathy 6.5%
Weight Decreased 5.6%
Dyspnoea 4.8%
White Blood Cell Count Decreased 4.0%
Abdominal Pain 3.2%
Gastrointestinal Disorder 3.2%
Injection Site Haematoma 3.2%
Respiratory Distress 3.2%
Vision Blurred 3.2%
Anxiety 2.4%
Back Pain 2.4%
Hypoglycaemic Seizure 2.4%
Influenza Like Illness 2.4%
Injection Site Pain 2.4%